Lannett Co. (LCI) to Submit NDA to U.S. FDA for Morphine Sulfate Products
Tweet Send to a Friend
Lannett Company, Inc. (AMEX: LCI) today announced plans to submit its New Drug Application (NDA) for its Morphine Sulfate products ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
